NEUPATH HEALTH INC (NPTH.CA) Stock Fundamental Analysis

TSX-V:NPTH • CA64133P1009

0.45 CAD
0 (0%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

NPTH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Providers & Services industry. NPTH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NPTH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • NPTH had negative earnings in the past year.
  • In the past year NPTH had a positive cash flow from operations.
  • In the past 5 years NPTH always reported negative net income.
  • NPTH had a positive operating cash flow in 4 of the past 5 years.
NPTH.CA Yearly Net Income VS EBIT VS OCF VS FCFNPTH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

  • The Return On Assets of NPTH (-1.20%) is comparable to the rest of the industry.
  • NPTH's Return On Equity of -2.63% is in line compared to the rest of the industry. NPTH outperforms 57.14% of its industry peers.
  • With an excellent Return On Invested Capital value of 5.06%, NPTH belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -1.2%
ROE -2.63%
ROIC 5.06%
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
NPTH.CA Yearly ROA, ROE, ROICNPTH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • NPTH has a better Operating Margin (2.76%) than 64.29% of its industry peers.
  • Looking at the Gross Margin, with a value of 19.25%, NPTH is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • NPTH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.76%
PM (TTM) N/A
GM 19.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
NPTH.CA Yearly Profit, Operating, Gross MarginsNPTH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NPTH is destroying value.
  • Compared to 1 year ago, NPTH has about the same amount of shares outstanding.
  • Compared to 5 years ago, NPTH has more shares outstanding
  • NPTH has a better debt/assets ratio than last year.
NPTH.CA Yearly Shares OutstandingNPTH.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
NPTH.CA Yearly Total Debt VS Total AssetsNPTH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 1.82 indicates that NPTH is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • NPTH has a better Altman-Z score (1.82) than 71.43% of its industry peers.
  • The Debt to FCF ratio of NPTH is 4.69, which is a neutral value as it means it would take NPTH, 4.69 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.69, NPTH is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • NPTH has a Debt/Equity ratio of 0.56. This is a neutral value indicating NPTH is somewhat dependend on debt financing.
  • NPTH's Debt to Equity ratio of 0.56 is amongst the best of the industry. NPTH outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.69
Altman-Z 1.82
ROIC/WACC0.72
WACC6.99%
NPTH.CA Yearly LT Debt VS Equity VS FCFNPTH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • NPTH has a Current Ratio of 1.12. This is a normal value and indicates that NPTH is financially healthy and should not expect problems in meeting its short term obligations.
  • NPTH has a better Current ratio (1.12) than 92.86% of its industry peers.
  • A Quick Ratio of 1.12 indicates that NPTH should not have too much problems paying its short term obligations.
  • With an excellent Quick ratio value of 1.12, NPTH belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12
NPTH.CA Yearly Current Assets VS Current LiabilitesNPTH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 34.21% over the past year.
  • NPTH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.67%.
  • Measured over the past years, NPTH shows a small growth in Revenue. The Revenue has been growing by 7.96% on average per year.
EPS 1Y (TTM)34.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.97%
Revenue 1Y (TTM)18.67%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.79%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NPTH.CA Yearly Revenue VS EstimatesNPTH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NPTH.CA Yearly EPS VS EstimatesNPTH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 0 0.02 -0.02 0.04 0.06

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • NPTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NPTH.CA Price Earnings VS Forward Price EarningsNPTH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NPTH is valued cheaper than 92.86% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, NPTH is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.81
EV/EBITDA 7.36
NPTH.CA Per share dataNPTH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for NPTH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEUPATH HEALTH INC

TSX-V:NPTH (2/12/2026, 7:00:00 PM)

0.45

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-26
Earnings (Next)05-13
Inst Owners10.95%
Inst Owner ChangeN/A
Ins Owners2.56%
Ins Owner ChangeN/A
Market Cap25.27M
Revenue(TTM)83.93M
Net Income(TTM)-553.00K
Analysts80
Price Target0.51 (13.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)15.78%
Min Revenue beat(2)10.97%
Max Revenue beat(2)20.6%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)17.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF 8.81
P/OCF 6.73
P/B 1.2
P/tB N/A
EV/EBITDA 7.36
EPS(TTM)-0.01
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0.05
FCFY11.36%
OCF(TTM)0.07
OCFY14.87%
SpS1.49
BVpS0.37
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.2%
ROE -2.63%
ROCE 7.03%
ROIC 5.06%
ROICexc 5.89%
ROICexgc 23.5%
OM 2.76%
PM (TTM) N/A
GM 19.25%
FCFM 3.42%
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
F-Score6
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.69
Debt/EBITDA 2.53
Cap/Depr 38.3%
Cap/Sales 1.06%
Interest Coverage 7.09
Cash Conversion 81.07%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z 1.82
F-Score6
WACC6.99%
ROIC/WACC0.72
Cap/Depr(3y)39.19%
Cap/Depr(5y)26.48%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.97%
EPS Next Y100%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.67%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%25.79%
Revenue Next Year22.77%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y103.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year308.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.94%
FCF growth 3Y3.23%
FCF growth 5YN/A
OCF growth 1Y20.57%
OCF growth 3Y10.75%
OCF growth 5YN/A

NEUPATH HEALTH INC / NPTH.CA FAQ

Can you provide the ChartMill fundamental rating for NEUPATH HEALTH INC?

ChartMill assigns a fundamental rating of 3 / 10 to NPTH.CA.


Can you provide the valuation status for NEUPATH HEALTH INC?

ChartMill assigns a valuation rating of 2 / 10 to NEUPATH HEALTH INC (NPTH.CA). This can be considered as Overvalued.


What is the profitability of NPTH stock?

NEUPATH HEALTH INC (NPTH.CA) has a profitability rating of 3 / 10.


What is the expected EPS growth for NEUPATH HEALTH INC (NPTH.CA) stock?

The Earnings per Share (EPS) of NEUPATH HEALTH INC (NPTH.CA) is expected to grow by 100% in the next year.